Insulin management

  • US 9,892,235 B2
  • Filed: 06/14/2017
  • Issued: 02/13/2018
  • Est. Priority Date: 01/31/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method comprising:

  • receiving, at data processing hardware, sequential blood glucose measurements of a patient, the sequential blood glucose measurements comprising a current blood glucose measurement measured at a current time;

    executing, by the data processing hardware, an intravenous treatment process configured to display on a screen in communication with the data processing hardware a graphical user interface, wherein the intravenous treatment process is configured to;

    display, in the graphical user interface, a patient information input window; and

    receive, in the patient information input window, patient information inputs from a medical professional to provide patient parameters for intravenous treatment of the patient, the patient parameters comprising;

    a target blood glucose range for the patient comprising a range of blood glucose values between and including a lower limit blood glucose value and an upper limit blood glucose value greater than the lower limit blood glucose value;

    a threshold hypoglycemia blood glucose value for the patient, the threshold hypoglycemia blood glucose value less than the lower limit blood glucose value of the target blood glucose range;

    a low blood glucose percentage drop limit for the patient when the current blood glucose measurement is less than the lower limit blood glucose value of the target blood glucose range;

    a regular blood glucose percentage drop limit for the patient when the current blood glucose measurement is greater than or equal to the lower limit blood glucose value of the target blood glucose range;

    a blood glucose drop limit for the patient; and

    a stable time period indicating a blood glucose concentration for the patient is stable in the target blood glucose range, the stable time period comprising one of a specified number of consecutive blood glucose measurements of the patient within the target blood glucose range or a recommended duration of time required for the current blood glucose measurement within the target blood glucose range to determine a blood glucose concentration for the patient is stable in the target blood glucose range;

    determining, by the data processing hardware, whether the current blood glucose measurement and one or more previous blood glucose measurements equal the specified number of consecutive blood glucose measurements within the target blood glucose range; and

    determining, by the data processing hardware, a next time interval from the current time until a next time of a next scheduled blood glucose measurement for the patient based on the current blood glucose measurement, the next time interval comprising a long time interval when the current blood glucose measurement and the one or more previous blood glucose measurements equal the specified number of consecutive blood glucose measurements within the target blood glucose range.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×